Alcohol Free Antiseptic
Cetylpyridinium Chloride
Rite Aid
Human Otc Drug
NDC 11822-5761Alcohol Free Antiseptic also known as Cetylpyridinium Chloride is a human otc drug labeled by 'Rite Aid'. National Drug Code (NDC) number for Alcohol Free Antiseptic is 11822-5761. This drug is available in dosage form of Mouthwash. The names of the active, medicinal ingredients in Alcohol Free Antiseptic drug includes Cetylpyridinium Chloride - .7 mg/mL . The currest status of Alcohol Free Antiseptic drug is Active.
Drug Information:
Drug NDC: | 11822-5761 |
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
Proprietary Name: | Alcohol Free Antiseptic |
Also known as the trade name. It is the name of the product chosen by the labeler. |
Product Type: | Human Otc Drug |
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
Non Proprietary Name: | Cetylpyridinium Chloride |
Also known as the generic name, this is usually the active ingredient(s) of the product. |
Labeler Name: | Rite Aid |
Name of Company corresponding to the labeler code segment of the ProductNDC. |
Dosage Form: | Mouthwash |
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
Status: | Active |
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
Substance Name: | CETYLPYRIDINIUM CHLORIDE - .7 mg/mL
|
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
Route Details: | ORAL
|
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Start Date: | 16 Dec, 2019 |
This is the date that the labeler indicates was the start of its marketing of the drug product. |
Marketing End Date: | 16 Jan, 2025 |
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
Application Number: | part356 |
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
Listing Expiration Date: | 31 Dec, 2024 |
This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name: | Rite Aid
|
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
Original Packager: | Yes
|
Whether or not the drug has been repackaged for distribution. |
UNII: | D9OM4SK49P
|
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
---|
11822-5761-2 | 1000 mL in 1 BOTTLE, PLASTIC (11822-5761-2) | 16 Dec, 2019 | N/A | No |
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antigingivitis, antiplaque
Product Elements:
Alcohol free antiseptic cetylpyridinium chloride cetylpyridinium chloride cetylpyridinium water glycerin poloxamer 188 saccharin sodium propylene glycol sodium benzoate sucralose benzoic acid fd&c blue no. 1
Indications and Usage:
Use helps control plaque {bacteria} that leads to gingivitis
Warnings:
Warnings for this product
Dosage and Administration:
Directions adults and children 6 years & older: rinse for 30 seconds with 20 ml (4 teaspoonfuls) twice a day do not swallow children 6 years to under 12 years of age: supervise use when used after brushing, rinse mouth with water first children under 6 years of age: do not use consult a dentist or doctor
Stop Use:
Stop use and ask a dentist if gingivitis, bleeding, or redness persists for more than 2 weeks you have painful or swollen gums, pus from the gum line, loose teeth or increased spacing between the teeth. these may be signs of symptoms of periodontitis, a serious form of gum disease.
Adverse Reactions:
Disclaimer distributed by: rite aid, 30 hunter lane camp hill, pa 17011 www.riteaid.com satisfaction guarantee: if you're not satisfied, we'll happily refund your money
Package Label Principal Display Panel:
Principal display panel sealed with printed neckband for your protection compare to crest pro-health multi-protection alcohol free rinse refreshing clean mint* multi-action alcohol free mouthwash antigingivitis/antiplaque rinse fresh mint kills germs helps prevent plaque & gingivitis helps keep teeth feeling clean freshens breath no burn of alcohol rite aid pharmacy 1l (33.8 fl oz) image description